“…Targeted Rock inhibition could serve as a potential therapeutic approach for many debilitating diseases, including cancer ( Itoh et al, 1999 ; Kuzelová and Hrkal, 2008 ; Narumiya et al, 2009 ; Liu et al, 2011 ), obesity ( Hara et al, 2011 ; Washida et al, 2011 ; Tokuyama et al, 2012 ), diabetes ( Biswas et al, 2011 ), hypertension ( Connolly and Aaronson, 2011 ), atherosclerosis ( Zhou et al, 2011 ), and cardiovascular diseases ( Dong et al, 2010 ). However, the Rock-Myosin II pathway is central to numerous cellular processes and signaling networks ( Wei et al, 2001 ; Thumkeo et al, 2003 ; Shimizu et al, 2005 ; Thumkeo et al, 2005 ; Kamijo et al, 2011 ), suggesting that global inhibition of Rock function would likely disrupt multiple cellular processes with detrimental side effects.…”